G1 Therapeutics (GTHX) Earnings Date, Estimates & Call Transcripts → Could Your Accounts Be Frozen? (From Allegiance Gold) (Ad) Free gthx Stock Alerts $4.49 +0.05 (+1.13%) (As of 05/3/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 7EstimatedActual EPS (May. 1) -$0.20 Missed By -$0.01 Consensus EPS (May. 1) -$0.19 Read Call TranscriptListen to Call Get G1 Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for GTHX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueGTHX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GTHX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. G1 Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.20)($0.20)($0.20)Q2 20242($0.18)($0.18)($0.18)Q3 20242($0.17)($0.14)($0.16)Q4 20242($0.14)($0.05)($0.10)FY 20248($0.69)($0.57)($0.63)Q1 20251($0.13)($0.13)($0.13)Q2 20251($0.13)($0.13)($0.13)Q3 20251($0.11)($0.11)($0.11)Q4 20251($0.11)($0.11)($0.11)FY 20254($0.48)($0.48)($0.48)GTHX Earnings Date and InformationG1 Therapeutics last released its earnings results on May 1st, 2024. The reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.19) by $0.01. The company earned $14.48 million during the quarter, compared to analysts' expectations of $15.21 million. G1 Therapeutics has generated ($0.62) earnings per share over the last year (($0.62) diluted earnings per share). Earnings for G1 Therapeutics are expected to grow in the coming year, from ($0.64) to ($0.26) per share. G1 Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off prior year's report dates.Read More G1 Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/7/2024Estimated)------- 5/1/2024Q1 2024($0.19)($0.20)($0.01)($0.20)$15.21 million$14.48 million 2/28/2024Q4 2023($0.27)($0.21)+$0.06($0.21)$12.83 million$14.87 million 11/1/2023Q3 2023($0.31)($0.35)($0.04)($0.35)$13.73 million$12.30 million8/2/2023Q2 2023($0.17)$0.14+$0.31$0.14$28.34 million$42.39 million5/3/2023Q1 2023($0.64)($0.53)+$0.11($0.53)$10.54 million$12.95 million3/1/2023Q4 2022($0.85)($0.73)+$0.12($0.73)$9.61 million$10.25 million Get the Latest News and Ratings for GTHX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for G1 Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/2/2022Q3 2022($0.64)($0.59)+$0.05($0.59)$22.64 million$23.58 million8/3/2022Q2 2022($1.04)($0.92)+$0.12($0.92)$9.00 million$10.57 million5/4/2022Q1 2022($0.99)($1.15)($0.16)($1.15)$5.78 million$6.90 million 2/23/2022Q4 2021($1.03)($0.94)+$0.09($0.94)$5.45 million$5.80 million 11/3/2021Q3 2021($1.03)($1.00)+$0.03($1.00)$4.31 million$4.86 million 8/4/2021Q2 2021($0.96)($0.94)+$0.02($0.94)$2.70 million$6.60 million 5/5/2021Q1 2021($1.09)($0.65)+$0.44($0.65)$0.37 million$14.22 million G1 Therapeutics Earnings - Frequently Asked Questions When is G1 Therapeutics's earnings date? G1 Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates. Learn more on GTHX's earnings history. Did G1 Therapeutics beat their earnings estimates last quarter? In the previous quarter, G1 Therapeutics (NASDAQ:GTHX) missed the analysts' consensus estimate of ($0.19) by $0.01 with a reported earnings per share (EPS) of ($0.20). Learn more on analysts' earnings estimate vs. GTHX's actual earnings. How can I listen to G1 Therapeutics's earnings conference call? The conference call for G1 Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read G1 Therapeutics's conference call transcript? The conference call transcript for G1 Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does G1 Therapeutics generate each year? G1 Therapeutics (NASDAQ:GTHX) has a recorded annual revenue of $82.51 million. How much profit does G1 Therapeutics generate each year? G1 Therapeutics (NASDAQ:GTHX) has a recorded net income of -$47.97 million. GTHX has generated -$0.62 earnings per share over the last four quarters. What is G1 Therapeutics's EPS forecast for next year? G1 Therapeutics's earnings are expected to grow from ($0.64) per share to ($0.26) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Foghorn Therapeutics Earnings Results Generation Bio Earnings Results Acrivon Therapeutics Earnings Results Merrimack Pharmaceuticals Earnings Results Prelude Therapeutics Earnings Results Ovid Therapeutics Earnings Results uniQure Earnings Results Galectin Therapeutics Earnings Results Aldeyra Therapeutics Earnings Results Design Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NASDAQ:GTHX) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldAutomatic Income (from home)Awesomely, LLCThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding G1 Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
